ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

U.S. FDA tracking pharmaceutical firms in Puerto Rico

by Britt E. Erickson
October 16, 2017 | APPEARED IN VOLUME 95, ISSUE 41

The U.S. Food & Drug Administration is working with pharmaceutical companies in Puerto Rico to prevent shortages of critical drugs in the aftermath of Hurricanes Irma and Maria. Puerto Rico is home to dozens of drug and medical device manufacturers, which are currently relying on generators for power. Commercial electricity is not expected to be restored on the island for several months. Although FDA is not saying which drugs are likely to be impacted by the back-to-back hurricanes, the agency released these statistics earlier this month:

▸ 40 pharmaceutical and medical device products could be in short supply.

▸ 30% of Puerto Rico’s gross domestic product is attributed to pharmaceuticals and medical devices.

▸ 80% of pharmaceuticals manufactured in Puerto Rico are consumed by U.S. citizens.

▸ 10% of all drugs consumed by Americans are made in Puerto Rico.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment